{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Is TENON Medical, Inc. overvalued or undervalued?
As of October 15, 2023, TENON Medical, Inc. is considered undervalued with a P/E ratio of 15.2 and a P/B ratio of 1.8, trading at a discount compared to peers like Stryker and Medtronic, and has recently outperformed the Sensex.
Is TENON Medical, Inc. technically bullish or bearish?
As of October 1, 2023, there is insufficient technical data for TENON Medical, Inc. to determine a bullish or bearish outlook.
What does TENON Medical, Inc. do?
TENON Medical, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of $1 million and a net loss of $4 million as of March 2025, with a market cap of $6.58 million. Key metrics include a negative P/E ratio, no dividend yield, and a price-to-book ratio of 0.70.
How big is TENON Medical, Inc.?
As of Jun 18, TENON Medical, Inc. has a market capitalization of 6.58 million, with net sales of 3.29 million and a net profit of -13.72 million over the latest four quarters. Shareholder's funds are 5.97 million, and total assets are 9.84 million.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
